REFERENCES
451.
Murakawa K, Abboud TK, Yanagi T: Neonatal responses
to alphaprodine administered during labor. Anesth Analg 65:392–394, 1986.
452.
Caraco Y, Tateishi T, Guengerich FP, Wood AJ:
Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.
Drug Metab Dispos 24:761–764, 1996.
453.
Parke TJ, Nandi PR, Bird KJ, Jewkes DA: Profound
hypotension following intravenous codeine phosphate. Three case reports and some
recommendations. Anaesthesia 47:852–854, 1992.
454.
Hill HF, Coda BA, Tanaka A, Schaffer R: Multiple-dose
evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects.
Anesth Analg 72:330–336, 1991.
455.
Wallenstein SL, Houde RW, Portenoy R, et al:
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone.
Pain 41:5–13, 1990.
456.
Rapp SE, Egan KJ, et al: A multidimensional comparison
of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 82:1043–1048,
1996.
457.
Gourlay GK, Willis RJ, Lamberty J: A double-blind
comparison of the efficacy of methadone and morphine in postoperative pain control.
Anesthesiology 64:322–327, 1986.
458.
Glass PS, Camporesi EM, Shafron D, et al: Evaluation
of pentamorphone in humans: A new potent opiate. Anesth Analg 68:302–307,
1989.
459.
Papazian L, Albanese J, Thirion X, et al: Effect
of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure
in patients with severe head injury. Br J Anaesth 71:267–271, 1993.
460.
Morlion B, Ebner E, Weber A, et al: Influence
of bolus size on efficacy of postoperative patient-controlled analgesia with piritramide.
Br J Anaesth 82:52–55, 1999.
461.
Bouillon T, Kietzmann D, Port R, et al: Population
pharmacokinetics of piritramide in surgical patients. Anesthesiology 90:7–15,
1999.
462.
Halfpenny DM, Callado LF, Hopwood SE, et al:
Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat
locus coeruleus measured by real time voltammetry. Br J Anaesth 83:909–915,
1999.
463.
Bamigbade TA, Davidson C, Langford RM, Stamford
JA: Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol,
on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. Br J Anaesth
79:352–356, 1997.
464.
de Wolff MH, Leather HA, Wouters PF: Effects
of tramadol on minimum alveolar concentration (MAC) of isoflurane in rats. Br J
Anaesth 83:780–783, 1999.
465.
James MF, Heijke SA, Gordon PC: Intravenous tramadol
versus epidural morphine for postthoracotomy pain relief: A placebo-controlled double-blind
trial. Anesth Analg 83:87–91, 1996.
466.
Vickers MD, O'Flaherty D, Szekely SM, et al:
Tramadol: Pain relief by an opioid without depression of respiration. Anaesthesia
47:291–296, 1992.
467.
Wilder Smith CH, Bettiga A: The analgesic tramadol
has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol 43:71–75,
1997.
468.
Pang WW, Huang PY, Chang DP, Huang MH: The peripheral
analgesic effect of tramadol in reducing propofol injection pain: A comparison with
lidocaine. Reg Anesth Pain Med 24:246–249, 1999.
469.
Acalovschi I, Cristea T, Margarit S, Gavrus R:
Tramadol added to lidocaine for intravenous regional anesthesia. Anesth Analg 92:209–214,
2001.
470.
Westman L, Valentin A, Eriksson E, Ekblom A:
Intrathecal administration of sameridine to patients subjected to arthroscopic knee
joint surgery. Acta Anaesthesiol Scand 42:691–697, 1998.
471.
Osterlund Modalen A, Arlander E, Eriksson LI,
Lindahl SG: The effects on hypercarbic ventilatory response of sameridine compared
to morphine and placebo. Anesth Analg 92:529–534, 2001.
472.
Osterlund A, Arlander E, Eriksson LI, Lindahl
SG: The effects on resting ventilation of intravenous infusions of morphine or sameridine,
a novel molecule with both local anesthetic and opioid properties. Anesth Analg
88:160–165, 1999.
473.
Sullivan AF, McQuay HJ, Bailey D, Dickenson AH:
The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide
and normorphine in the rat. Brain Res 482:219–224, 1989.
474.
Osborne R, Thompson P, Joel S, et al: The analgesic
activity of morphine-6-glucuronide. Br J Clin Pharmacol 34:130–138, 1992.
475.
Grace D, Fee JP: A comparison of intrathecal
morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip
replacement. Anesth Analg 83:1055–1059, 1996.
476.
Asai T, Mapleson WW, Power I: Effects of nalbuphine,
pentazocine and U50488H on gastric emptying and gastrointestinal transit in the rat.
Br J Anaesth 80:814–819, 1998.
477.
Bowdle TA, Greichen SL, Bjurstrom RL, Schoene
RB: Butorphanol improves CO2
response and ventilation after fentanyl
anesthesia. Anesth Analg 66:517–522, 1987.
478.
Pedersen JE, Chraemmer Jorgensen B, Schnidt JF,
Risbo A: Naloxone—a strong analgesic in combination with high-dose buprenorphine.
Br J Anaesth 57:1045–1046, 1985.
479.
Gal TJ: Naloxone reversal of buprenorphine-induced
respiratory depression. Clin Pharmacol Ther 45:66–71, 1989.
480.
Obel D, Hansen LK, Huttel MS, Andersen PK: Buprenorphine-supplemented
anaesthesia. Influence of dose on duration of analgesia after cholecystectomy.
Br J Anaesth 57:271–274, 1985.
481.
De Souza EB, Schmidt WK, Kuhar MJ: Nalbuphine:
An autoradiographic opioid receptor binding profile in the central nervous system
of an agonist/antagonist analgesic. J Pharmacol Exp Ther 244:391–402, 1988.
482.
Lee SC, Wang JJ, Ho ST, Tao PL: Nalbuphine coadministered
with morphine prevents tolerance and dependence. Anesth Analg 84:810–815,
1997.
483.
Sury MR, Cole PV: Nalbuphine combined with midazolam
for outpatient sedation. An assessment of safety in volunteers. Anaesthesia 43:281–284,
1988.
484.
Garfield JM, Garfield FB, Philip BK, et al: A
comparison of clinical and psychological effects of fentanyl and nalbuphine in ambulatory
gynecologic patients. Anesth Analg 66:1303–1307, 1987.
485.
Parker RK, Holtmann B, White PF: Patient-controlled
epidural analgesia: interactions between nalbuphine and hydromorphone. Anesth Analg
84:757–763, 1997.
486.
Murphy MR, Hug CC Jr: The enflurane sparing effect
of morphine, butorphanol, and nalbuphine. Anesthesiology 57:489–492, 1982.
487.
Bailey PL, Clark NJ, Pace NL, et al: Failure
of nalbuphine to antagonize morphine: A double-blind comparison with naloxone.
Anesth Analg 65:605–611, 1986.
488.
Latasch L, Probst S, Dudziak R: Reversal by nalbuphine
of respiratory depression caused by fentanyl. Anesth Analg 63:814–816, 1984.
489.
Ramsay JG, Higgs BD, Wynands JE, et al: Early
extubation after high-dose fentanyl anaesthesia for aortocoronary bypass surgery:
reversal of respiratory depression with low-dose nalbuphine. Can Anaesth Soc J
32:597–606, 1985.
490.
Moldenhauer CC, Roach GW, Finlayson DC, et al:
Nalbuphine antagonism of ventilatory depression following high-dose fentanyl anesthesia.
Anesthesiology 62:647–650, 1985.
491.
Jaffe RS, Moldenhauer CC, Hug CC Jr, et al: Nalbuphine
antagonism of fentanyl-induced ventilatory depression: A randomized trial. Anesthesiology
68:254–260, 1988.
492.
Bailey PL, Clark NJ, Pace NL, et al: Antagonism
of postoperative opioid-induced respiratory depression: Nalbuphine versus naloxone.
Anesth Analg 66:1109–1114, 1987.
493.
Gal TJ, DiFazio CA: Ventilatory and analgesic
effects of dezocine in humans. Anesthesiology 61:716–722, 1984.
494.
Hall RI, Murphy MR, Szlam F, Hug CC Jr: Dezocine-MAC
reduction and evidence for myocardial depression in the presence of enflurane. Anesth
Analg 66:1169–2274, 1987.
495.
Galloway FM, Varma S: Double-blind comparison
of intravenous doses of dezocine, butorphanol, and placebo for relief of postoperative
pain. Anesth Analg 65:283–287, 1986.
496.
Kaiko RF, Wallenstein SL, Rogers AG, et al: Intramuscular
meptazinol and morphine in postoperative pain. Clin Pharmacol Ther 37:589–596,
1985.
497.
Wilkinson DJ, O'Connor SA, Dickson GR, Drake HF:
Meptazinol—a cause of respiratory depression in general anaesthesia. Br J
Anaesth 57:1077–1084, 1985.
498.
Kendrick WD, Woods AM, Daly MY, et al: Naloxone
versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus.
Anesth Analg 82:641–647, 1996.
499.
Gan TJ, Ginsberg B, Glass PS, et al: Opioid-sparing
effects of a low-dose infusion of naloxone in patient-administered morphine sulfate.
Anesthesiology 87:1075–1081, 1997.
500.
Asai T, Power I: Naloxone inhibits gastric emptying
in the rat. Anesth Analg 88:204–208, 1999.
501.
Fukuda K, Kato S, Shoda T, et al: Partial agonistic
activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic
acids in Chinese hamster ovary cells. Anesth Analg 87:450–455, 1998.
502.
Prough DS, Roy R, Bumgarner J, Shannon G: Acute
pulmonary edema in healthy teenagers following conservative doses of intravenous
naloxone. Anesthesiology 60:485–486, 1984.
503.
Partridge BL, Ward CF: Pulmonary edema following
low-dose naloxone administration. Anesthesiology 65:709–710, 1986.
504.
Kulig K: Initial management of ingestions of
toxic substances. N Engl J Med 326:1677–1681, 1992.
505.
Just B, Delva E, Camus Y, Lienhart A: Oxygen
uptake during recovery following naloxone. Relationship with intraoperative heat
loss. Anesthesiology 76:60–4, 1992.
506.
Mannelli M, Maggi M, De Feo ML, et al: Naloxone
administration releases catecholamines. N Engl J Med 308:654–655, 1983.
507.
Kraynack BJ, Gintautas JG: Naloxone: Analeptic
action unrelated to opiate receptor antagonism? Anesthesiology 56:251–253,
1982.
508.
Beilin B, Vatashsky E, Aronson HB, Weinstock M:
Naloxone reversal of postoperative apnea in a premature infant. Anesthesiology
63:317–318, 1985.
509.
Delle M, Ricksten SE, Thoren P: The opiate antagonist
naloxone counteracts the inhibition of sympathetic nerve activity caused by halothane
anesthesia in rats. Anesthesiology 70:309–317, 1989.
510.
Skarphedinsson JO, Delle M, Hoffman P, Thoren
P: The effects of naloxone on cerebral blood flow and cerebral function during relative
cerebral ischemia. J Cereb Blood Flow Metab 9:515–522, 1989.
511.
Romanovsky AA, Blatteis CM: Heat stroke: Opioid-mediated
mechanisms. J Appl Physiol 81:2565–2570, 1996.
512.
Glass PS, Jhaveri RM, Smith LR: Comparison of
potency and duration of action of nalmefene and naloxone. Anesth Analg 78:536–541,
1994.
513.
Joshi GP, Duffy L, Chehade J, et al: Effects
of prophylactic nalmefene on the incidence of morphine-related side effects in patients
receiving intravenous patient-controlled analgesia. Anesthesiology 90:1007–1011,
1999.
514.
Yuan CS, Foss JF, O'Connor M, et al: Methylnaltrexone
for reversal of constipation due to chronic methadone use: A randomized controlled
trial. JAMA 283:367–372, 2000.
515.
Murphy DB, El Behiery H, Chan VW, Foss JF: Pharmacokinetic
profile of epidurally administered methylnaltrexone, a novel peripheral opioid antagonist
in a rabbit model. Br J Anaesth 86:120–122, 2001.
516.
Bovill JG: Adverse drug interactions in anesthesia.
J Clin Anesth 9(Suppl):3S–13S, 1997.
517.
Vuyk J: Pharmacokinetic and pharmacodynamic interactions
between opioids and propofol. J Clin Anesth 9(Suppl):23–26, 1997.
518.
Tverskoy M, Fleyshman G, Ezry J, et al: Midazolam-morphine
sedative interaction in patients. Anesth Analg 68:282–285, 1989.
519.
Kissin I, Brown PT, Bradley EL Jr, et al: Diazepam-morphine
hypnotic synergism in rats. Anesthesiology 70:689–694, 1989.
520.
Schwieger IM, Hall RI, Hug CC Jr: Less than additive
antinociceptive interaction between midazolam and fentanyl in enflurane-anesthetized
dogs. Anesthesiology 74:1060–1066, 1991.
521.
Kissin I, Brown PT, Bradley EL Jr: Morphine and
fentanyl anesthetic interactions with diazepam: Relative antagonism in rats. Anesth
Analg 71:236–241, 1990.
522.
Luger TJ, Hayashi T, Weiss CG, Hill HF: The spinal
potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced
analgesia in rats. Eur J Pharmacol 275:153–162, 1995.
523.
Vinik HR, Bradley EL Jr, Kissin I: Midazolam-alfentanil
synergism for anesthetic induction in patients. Anesth Analg 69:213–217, 1989.
524.
Bailey PL, Pace NL, Ashburn MA, et al: Frequent
hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 73:826–830,
1990.
525.
Spiess BD, Sathoff RH, el Ganzouri AR, Ivankovich
AD: High-dose sufentanil: Four cases of sudden hypotension on induction. Anesth
Analg 65:703–705, 1986.
526.
Takkunen O, Meretoja OA: Thiopentone reduces
the haemodynamic response to induction of high-dose fentanyl-pancuronium anaesthesia
in coronary artery surgical patients. Acta Anaesthesiol Scand 32:222–227,
1988.
527.
Lepage JY, Pinaud ML, Helias JH, et al: Left
ventricular function during propofol and fentanyl anesthesia in patients with coronary
artery disease: Assessment with a radionuclide approach. Anesth Analg 67:949–955,
1988.
528.
Hall RI, Murphy JT, Moffitt EA, et al: A comparison
of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil
and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft
surgery. Can J Anaesth 38:996–1004, 1991.
529.
Iselin Chaves IA, Flaishon R, Sebel PS, et al:
The effect of the interaction of propofol and alfentanil on recall, loss of consciousness,
and the Bispectral Index. Anesth Analg 87:949–955, 1998.
530.
Han T, Kim D, Kil H, Inagaki Y: The effects of
plasma fentanyl concentrations on propofol requirement, emergence from anesthesia,
and postoperative analgesia in propofolnitrous oxide anesthesia. Anesth Analg 90:1365–1371,
2000.
531.
Sukhani R, Vazquez J, Pappas AL, et al: Recovery
after propofol with and without intraoperative fentanyl in patients undergoing ambulatory
gynecologic laparoscopy. Anesth Analg 83:975–981, 1996.
532.
Haessler R, Madler C, Klasing S, et al: Propofol/fentanyl
versus etomidate/fentanyl for the induction of anesthesia in patients with aortic
insufficiency and coronary artery disease. J Cardiothorac Vasc Anesth 6:173–180,
1992.
533.
Sethna NF, Liu M, Gracely R, et al: Analgesic
and cognitive effects of intravenous ketamine-alfentanil combinations versus either
drug alone after intradermal capsaicin in normal subjects. Anesth Analg 86:1250–1256,
1998.
534.
Reeves M, Lindholm DE, Myles PS, et al: Adding
ketamine to morphine for patient-controlled analgesia after major abdominal surgery:
A double-blinded, randomized controlled trial. Anesth Analg 93:116–120, 2001.
535.
Lauretti GR, Lima IC, Reis MP, et al: Oral ketamine
and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for
cancer pain management. Anesthesiology 90:1528–1533, 1999.
536.
Eckhardt K, Ammon S, Hofmann U, et al: Gabapentin
enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 91:185–191,
2000.
537.
Hara K, Saito Y, Kirihara Y, et al: The interaction
of antinociceptive effects of morphine and GABA receptor agonists within the rat
spinal cord. Anesth Analg 89:422–427, 1999.
538.
Philbin DM, Foex P, Drummond G, et al: Postsystolic
shortening of canine left ventricle supplied by a stenotic coronary artery when nitrous
oxide is added in the presence of narcotics. Anesthesiology 62:166–174, 1985.
539.
Cahalan MK, Prakash O, Rulf EN, et al: Addition
of nitrous oxide to fentanyl anesthesia does not induce myocardial ischemia in patients
with ischemic heart disease. Anesthesiology 67:925–929, 1986.
540.
Finck AD, Samaniego E, Ngai SH: Nitrous oxide
selectively releases Met5-enkephalin and Met5-enkephalin-Arg6-Phe7 into canine third
ventricular cerebrospinal fluid. Anesth Analg 80:664–670, 1995.
541.
Heikkila H, Jalonen J, Arola M, et al: Low-dose
enflurane as adjunct to high-dose fentanyl in patients undergoing coronary artery
surgery: Stable hemodynamics and maintained myocardial oxygen balance. Anesth Analg
66:111–116, 1987.
542.
O'Young J, Mastrocostopoulos G, Hilgenberg A,
et al: Myocardial circulatory and metabolic effects of isoflurane and sufentanil
during coronary artery surgery. Anesthesiology 66:653–658, 1987.
543.
Vermeyen KM, Erpels FA, Beeckman CP, et al: Low-dose
sufentanil-isoflurane anaesthesia for coronary artery surgery. Br J Anaesth 63:44–50,
1989.
544.
Phillips AS, McMurray TJ, Mirakhur RK, et al:
Propofolfentanyl anesthesia: A comparison with isoflurane-fentanyl anesthesia in
coronary artery bypass grafting and valve replacement surgery. J Cardiothorac Vasc
Anesth 8:289–296, 1994.
545.
Searle NR, Martineau RJ, Conzen P, et al: Comparison
of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass
surgery. Sevoflurane Venture Group. Can J Anaesth 43:890–899, 1996.
546.
Weiskopf RB, Eger EI 2nd, Noorani M, Daniel M:
Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation
induced by desflurane in humans. Anesthesiology 81:1350–1355, 1994.
547.
Ebert TJ, Muzi M: Sympathetic hyperactivity during
desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology
79:444–453, 1993.
548.
Cote D, Martin R, Tetrault JP: Haemodynamic interactions
of muscle relaxants and sufentanil in coronary artery surgery. Can J Anaesth 38:324–329,
1991.
549.
Thomson IR, MacAdams CL, Hudson RJ, Rosenbloom
M: Drug interactions with sufentanil. Hemodynamic effects of premedication and
muscle relaxants. Anesthesiology 76:922–929, 1992.
550.
Thomson IR, Putnins CL: Adverse effects of pancuronium
during high-dose fentanyl anesthesia for coronary artery bypass grafting. Anesthesiology
62:708–713, 1985.
551.
Sethna DH, Starr NJ, Estafanous FG: Cardiovascular
effects of non-depolarizing neuromuscular blockers in patients with coronary artery
disease. Can Anaesth Soc J 33:280–286, 1986.
552.
Paulissian R, Mahdi M, Joseph NJ, et al: Hemodynamic
responses to pancuronium and vecuronium during high-dose fentanyl anesthesia for
coronary artery bypass grafting. J Cardiothorac Vasc Anesth 5:120–125, 1991.
553.
Heinonen J, Salmenpera M, Suomivuori M: Contribution
of muscle relaxant to the haemodynamic course of high-dose fentanyl anaesthesia:
A comparison of pancuronium, vecuronium and atracurium. Can Anaesth Soc J 33:597–605,
1986.
554.
O'Connor JP, Ramsay JG, Wynands JE, et al: The
incidence of myocardial ischemia during anesthesia for coronary artery bypass surgery
in patients receiving pancuronium or vecuronium. Anesthesiology 70:230–236,
1989.
555.
Waldmann CS, Wark KJ, Sebel PS, Feneck RO: Hemodynamic
effects of atracurium, vecuronium and pancuronium during sufentanil anesthesia for
coronary artery bypass. Acta Anaesthesiol Scand 30:351–356, 1986.
556.
Stoops CM, Curtis CA, Kovach DA, et al: Hemodynamic
effects of doxacurium chloride in patients receiving oxygen sufentanil anesthesia
for coronary artery bypass grafting or valve replacement. Anesthesiology 69:365–370,
1988.
557.
Tassonyi E, Neidhart P, Pittet JF, et al: Cardiovascular
effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass
grafting. Anesthesiology 69:793–796, 1988.
558.
Savarese JJ, Ali HH, Basta SJ, et al: The cardiovascular
effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate
anesthesia. Anesthesiology 70:386–394, 1089.
559.
Choi WW, Mehta MP, Murray DJ, et al: Neuromuscular
and cardiovascular effects of mivacurium chloride in surgical patients receiving
nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia. Can J Anaesth 36:641–650,
1989.
560.
Stoops CM, Curtis CA, Kovach DA, et al: Hemodynamic
effects of mivacurium chloride administered to patients during oxygen-sufentanil
anesthesia for coronary artery bypass grafting or valve replacement. Anesth Analg
68:333–339, 1989.
561.
Wells DG, Bjorksten AR: Monoamine oxidase inhibitors
revisited. Can J Anaesth 36:64–74, 1989.
562.
Stack CG, Rogers P, Linter SP: Monoamine oxidase
inhibitors and anaesthesia. A review. Br J Anaesth 60:222–227, 1988.
563.
Carta F, Bianchi M, Argenton S, et al: Effect
of nifedipine on morphine-induced analgesia. Anesth Analg 70:493–498, 1990.
564.
Omote K, Sonoda H, Kawamata M, et al: Potentiation
of antinociceptive effects of morphine by calcium-channel blockers at the level of
the spinal cord. Anesthesiology 79:746–752, 1993.
565.
Hasegawa AE, Zacny JP: The influence of three
L-type calcium channel blockers on morphine effects in healthy volunteers. Anesth
Analg 85:633–638, 1997.
566.
Omote K, Kawamata M, Satoh O, et al: Spinal antinociceptive
action of an N-type voltage-dependent calcium channel blocker and the synergistic
interaction with morphine. Anesthesiology 84:636–643, 1996.
567.
Bartkowski RR, Goldberg ME, Huffnagle S, Epstein
RH: Sufentanil disposition. Is it affected by erythromycin administration? Anesthesiology
78:260–265, 1993.
568.
Bartkowski RR, McDonnell TE: Prolonged alfentanil
effect following erythromycin administration. Anesthesiology 73:566–568, 1990.
569.
Koinig H, Wallner T, Marhofer P, et al: Magnesium
sulfate reduces intra- and postoperative analgesic requirements. Anesth Analg 87:206–210,
1998.
570.
Buvanendran A, McCarthy RJ, Kroin JS, et al:
Intrathecal magnesium prolongs fentanyl analgesia: A prospective, randomized, controlled
trial. Anesth Analg 95:661–666, 2002.
571.
Kroin JS, McCarthy RJ, Von Roenn N, et al: Magnesium
sulfate potentiates morphine antinociception at the spinal level. Anesth Analg 90:913–917,
2000.
572.
Plummer JL, Owen H, Ilsley AH, Tordoff K: Sustained-release
ibuprofen as an adjunct to morphine patient-controlled analgesia. Anesth Analg 83:92–96,
1996.
573.
Ng A, Parker J, Toogood L, Cotton BR, Smith G:
Does the opioid-sparing effect of rectal diclofenac following total abdominal hysterectomy
benefit the patient? Br J Anaesth 88:714–716, 2002.
574.
Moren J, Francois T, Blanloeil Y, Pinaud M: The
effects of a nonsteroidal antiinflammatory drug (ketoprofen) on morphine respiratory
depression: A double-blind, randomized study in volunteers. Anesth Analg 85:400–405,
1997.
575.
Babenco HD, Blouin RT, Conard PF, Gross JB: Diphenylhydramine
increases ventilatory drive during alfentanil infusion. Anesthesiology 89:642–647,
1998.
